25.07.2016 • NewsElaine BurridgePKN Orlenpropylene

PKN Orlen Hikes Propylene Capacity

(c) Thomas Henderson/Getty Images
(c) Thomas Henderson/Getty Images

Polish petrochemicals group PKN Orlen is to build a metathesis unit at its site in Plock. The unit will add capacity of 100,000 t/y polymer-grade propylene taking total output to 550,000 t/y. The project, costing around 400 million zloty (€92 million), has been approved by the company’s management and supervisory boards.

Technology is being licensed from Lummus Technology, a division of US contractor CB&I, which is also providing technical and engineering consulting services. President of PKN Orlen’s management board, Wojciech Jasiński, said the company wanted to maximize capacity utilization and boost integration between its petrochemical and refining areas, giving it flexibility to respond to changes in demand for fuels and petrochemicals.

Metathesis technology can process refinery-based C4 feedstocks to maximize propylene output. The group said its strategy provided for capital expenditure of 1.6 billion zloty on key petrochemical projects up to 2017. It did not disclose how much of that sum has been spent to date.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.